MILWAUKEE--(BUSINESS WIRE)--APN Health, LLC (www.apnhealth.com) announces its Navik 3D mapping system is commercially released and in clinical use. The first clinical case using the technology was performed on March 22nd at St. Luke’s Medical center in Milwaukee.
Navik 3D is intended for catheter-based atrial and ventricular mapping using compatible catheters and acquired data from compatible fluoroscopy systems and patient recording and monitoring systems. Navik 3D is intended to provide 3D location of these catheters from acquired 2D fluoroscopic images. The device allows real-time display of cardiac maps in a number of different formats, including anatomical maps, cardiac electrical activation maps and cardiac voltage maps.
Navik 3D is the first open platform cardiac mapping technology that does not require any custom equipment and can identify 3D catheter locations in the heart and create three dimensional maps of the cardiac chamber of interest.
“At APN Health, we have an outstanding team of engineers and clinicians who have come together to build an exciting technology that is going to compete and deliver a significantly more innovative and cost-effective solution in the EP space within the Cardiology domain,” said David Geddam who is the Vice President of Product Development and Operations for APN Health, LLC.
Navik 3D is being rolled out to select US and international customers with a full roll out expected to be in the next 6 to 12 months.
About APN Health, LLC
APN Health, LLC is focused on advancing the tools available in electrophysiology. APN's goal is to provide electrophysiologists with critical information to deliver appropriate treatment for heart rhythm disorders and thereby improve patient outcomes. Jasbir Sra, MD founded APN Health to provide intuitive, cost effective, and simple to use accurate 3D mapping tools to physicians throughout the world. For additional information, please visit http://www.apnhealth.com.